LAG-3 — Drug Target
All drugs that target LAG-3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 1 pipeline (1)
- ALT803 · Brenda Cooper, MD · Immune checkpoint inhibitor · Oncology
Nucleic acid-based immunotherapy